透云生物(01332.HK) 公布，全资子公司山西透云于11月20日收到国家卫生健康委员会通知，其申报的“莱茵衣藻(白藻)”(后更名为“莱茵衣藻”)的行政许可申请，与国家卫生健康委员会2022年第2号公告的莱茵衣藻实质等同。据此，集团生产的莱茵衣藻应用范围和空间扩展，并开始进入人造鱼、虾以及植物奶市场。(gc/a)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.